Parkinson's Disease Global Clinical Trials Review, H1, 2018

  • ID: 4559023
  • Clinical Trials
  • Region: Global
  • 854 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Bial - Portela & Ca SA
  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc
  • The Lundbeck Foundation
  • MORE
Parkinson's Disease Global Clinical Trials Review, H1, 2018

Summary

The author's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H1, 2018" provides an overview of Parkinson's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Parkinson's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Bial - Portela & Ca SA
  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc
  • The Lundbeck Foundation
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Parkinson's Disease to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Parkinson's Disease to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Parkinson's Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Parkinson's Disease
  • Apr 30, 2018: Elto PharmaAppoints Paula Trzepacz, MD as Chief Medical Advisor
  • Apr 26, 2018: Intra-Cellular Therapies Presents Data on ITI-214 at the 2018 American Academy of Neurology Annual Meeting
  • Apr 24, 2018: Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting
  • Apr 19, 2018: Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI in Parkinson's Disease Patients with Dyskinesia
  • Apr 18, 2018: Mitsubishi Tanabe Pharma America and NeuroDerm Announce Parkinson's Disease Presentations at American Academy of Neurology Annual Meeting
  • Apr 17, 2018: Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX2-73 in Parkinson’s Disease Dementia and Provides Clinical Study Update for ANAVEX2-73 in Rett Syndrome
  • Apr 12, 2018: Adamas Announces Data Presentations on GOCOVRI at The American Academy Of Neurology Annual Meeting
  • Apr 12, 2018: Bumetanide strikes again in the arena of neurological disorders: a novel therapeutic approach to treat Parkinson’s disease
  • Apr 10, 2018: Approval For Rotigotine Extended Release Microspheres For Injection From Phase III Clinical Trials In China
  • Apr 04, 2018: Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting
  • Apr 03, 2018: Intec Pharma to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease
  • Mar 29, 2018: Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease
  • Mar 26, 2018: Enterin's Phase 2a RASMET Study in Patients With Parkinson's Disease Completes Enrollment
  • Mar 15, 2018: Biogen to Present at the 2018 Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting
  • Mar 15, 2018: Aptinyx Presents Data on NMDA Receptor Modulator NYX-458 in a Preclinical Model of Parkinson's Cognitive Impairment at the AAT-AD/PD Focus Meeting 2018
  • Mar 15, 2018: Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI in Parkinson Disease Patients with Dyskinesia
  • Mar 09, 2018: Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease
  • Mar 05, 2018: International Stem Cell Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial
  • Feb 27, 2018: Hisamitsu Pharmaceutical Announces the Results of Phase III Clinical Study of HP-3000 in Japan
  • Feb 26, 2018: Cantabio Pharmaceuticals to Present Results from its Tau Protein Targeting Therapeutic Program for the treatment of Alzheimer Disease at the Advances in Alzheimer and Parkinson Therapies, An AAT-AD/PD Focus Meeting in Torino, Italy
  • Feb 26, 2018: Genervon Presents Innovative CNS Drug Candidate at 2018 BIO CEO & Investor Conference
  • Feb 08, 2018: Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical Practice
  • Feb 08, 2018: Rotigotine Extended Release Microspheres For Injection Exempted From Phase II Clinical Trials in the United States
  • Feb 06, 2018: First Patients Dosed in Phase III Multi-center, Multinational Study to Determine the Efficacy, Safety and Tolerability of P2B001 in Patients with Early Stage Parkinson's Disease
  • Jan 31, 2018: IRLAB Provides Update On Clinical Phase II pipeline - IRL752
  • Jan 31, 2018: IRLAB Provides Update On Clinical Phase II pipeline - IRL790
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Source
List of Tables
  • Parkinson's Disease Therapeutics, Global, Clinical Trials by Region, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
  • Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2018*
  • Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2018*
  • Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Parkinson's Disease Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
  • Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2018*
  • Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Parkinson's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Parkinson's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2018*
  • Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Parkinson's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Parkinson's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Parkinson's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • UCB SA
  • C. H. Boehringer Sohn AG & Co KG
  • Bial - Portela & Ca SA
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Newron Pharmaceuticals SpA
  • AbbVie Inc
  • GlaxoSmithKline Plc
  • The Lundbeck Foundation
  • Pfizer Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll